Antithymocyte Globulin for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation

J Clin Oncol. 2017 Dec 20;35(36):3993-3995. doi: 10.1200/JCO.2017.76.0512. Epub 2017 Oct 31.

Authors

Mohamad Mohty¹, Florent Malard¹

Affiliation

¹ Mohamad Mohty and Florent Malard, Hôpital Saint-Antoine; Université Pierre & Marie Curie; and INSERM, Centre de Recherche Saint-Antoine, UMRs U938, Paris, France.

PMID: 29087771
DOI: 10.1200/JCO.2017.76.0512

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antilymphocyte Serum
Double-Blind Method
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans
Prospective Studies
T-Lymphocytes

Substances

Antilymphocyte Serum